Histopathologic correlates of myocardial improvement in patients supported by a left ventricular assist device

被引:0
|
作者
Segura, Ana Maria [1 ]
Frazier, O. H. [2 ]
Demirozu, Zumrut [2 ]
Buja, L. Maximilian [1 ,3 ]
机构
[1] St Lukes Episcopal Hosp, Texas Heart Inst, Dept Cardiovasc Pathol, Houston, TX 77225 USA
[2] St Lukes Episcopal Hosp, Texas Heart Inst, Dept Cardiovasc Transplantat, Houston, TX 77225 USA
[3] Univ Texas Hlth Sci Ctr, Dept Pathol & Lab Med, Houston, TX USA
关键词
Heart-assist device; Hypertrophy; Myocardium; Myocyte; Remodeling; Transplantation; MECHANICAL CIRCULATORY SUPPORT; CARDIAC RECOVERY; HEART-FAILURE; LVAD SUPPORT; CARDIOMYOPATHY; HYPERTROPHY; REGRESSION; FIBROSIS; REVERSAL; BRIDGE;
D O I
10.1016/j.carpath.2010.01.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Left ventricular assist devices unload the failing heart and improve hemodynamic function and tissue architecture. In some patients improvement allows for left ventricular assist device removal. We retrospectively compared histologic features in patients who were weaned off left ventricular assist device support with those who remained on support without evidence of clinical remission. Methods: We graded left ventricular core samples taken at implantation on a scale we designed for evaluating severity and extent of fibrosis and hypertrophy. We correlated the grades with a computerized semiquantitative analysis of picrosirius-red and Masson's trichrome-stained sections. We evaluated interstitial (10x), perivascular (20x), and replacement (4x) fibrosis. Hypertrophy was assessed by myocyte diameter, cytoplasmic area, and nuclear/cytoplasmic ratio. Results: All patients (N=17) underwent left ventricular assist device implantation for heart failure. In eight patients improvement allowed left ventricular assist device removal. The groups did not differ in age (24.1 vs. 25 years, P=.4) or mean time on left ventricular assist device support (506 vs. 414 days, P=.24). All mean measures showed significantly less hypertrophy in the left ventricular assist device-removal group than in the nonremoval group, respectively (cytoplasmic area, 58.00 vs. 77.18 mu m(2), P=.021; myocyte diameter, 20.32 vs. 25.35 mu m, P=.004; nuclear/cytoplasmic ratio, 11.04 vs. 8.69, P=.053). Although not statistically significant, the left ventricular assist device-removal group tended toward less overall fibrosis than the nonremoval group (11.57 vs. 13.24, P=.214). Conclusions: Left ventricular assist device-removal patients had less hypertrophy and fibrosis overall than did nonremoval patients. These findings may help identify patients with a higher probability of left ventricular assist device removal and myocardial recovery. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:139 / 145
页数:7
相关论文
共 50 条
  • [1] Assessment of myocardial viability and left ventricular function in patients supported by a left ventricular assist device
    Gupta, Deepak K.
    Skali, Hicham
    Rivero, Jose
    Campbell, Patricia
    Griffin, Leslie
    Smith, Colleen
    Foster, Courtney
    Claggett, Brian
    Glynn, Robert J.
    Couper, Gregory
    Givertz, Michael M.
    Mehra, Mandeep R.
    Di Carli, Marcelo
    Solomon, Scott D.
    Pfeffer, Marc A.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : 372 - 381
  • [2] Longitudinal assessment of myocardial viability and left ventricular function in patients supported by a left ventricular assist device
    Gupta, D.
    Skali, H.
    Rivero, J.
    Campbell, P.
    Couper, G.
    Givertz, M.
    Mehra, M.
    Di Carli, M.
    Solomon, S.
    Pfeffer, M.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S215 - S215
  • [3] Improvement of myocardial perfusion with a percutaneously inserted left ventricular assist device
    Raed A. Aqel
    Fadi G. Hage
    Ami E. Iskandrian
    [J]. Journal of Nuclear Cardiology, 2010, 17 : 158 - 160
  • [4] Improvement of myocardial perfusion with a percutaneously inserted left ventricular assist device
    Aqel, Raed A.
    Hage, Fadi G.
    Iskandrian, Ami E.
    [J]. JOURNAL OF NUCLEAR CARDIOLOGY, 2010, 17 (01) : 158 - 160
  • [5] Quality of life for patients supported on a left ventricular assist device
    MacIver, Jane
    Rao, Vivek
    Ross, Heather J.
    [J]. EXPERT REVIEW OF MEDICAL DEVICES, 2011, 8 (03) : 325 - 337
  • [6] A Case Series of Acute Myocardial Infarction in Left Ventricular Assist Device-Supported Patients
    Godishala, Anuradha
    Nassif, Michael E.
    Raymer, David S.
    Hartupee, Justin
    Ewald, Gregory A.
    Larue, Shane J.
    Vader, Justin M.
    [J]. ASAIO JOURNAL, 2017, 63 (02) : E18 - E24
  • [7] Myocardial Hypertrophy at Implantation Correlates with Duration of Left Ventricular Assist Device Support
    Segura, A. M.
    Frazier, O. H.
    Buja, L. M.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S305 - S306
  • [8] Catheter Ablation of Ventricular Arrhythmias in Patients Supported by Left Ventricular Assist Device
    Garan, A. R.
    Han, J.
    Nahumi, N.
    Yuzefpolskaya, M.
    Colombo, P.
    Whang, W.
    Morrow, J.
    Garan, H.
    Jorde, U. P.
    Uriel, N.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S228 - S228
  • [9] Histological Markers of Myocardial Improvement During Left Ventricular Assist Device Support
    Segura, Ana Maria
    Frazier, O. Howard
    Buis, L. Maximilian
    [J]. CIRCULATION, 2008, 118 (18) : S799 - S800
  • [10] Exercise in heart failure patients supported with a left ventricular assist device
    Jung, Mette Holme
    Gustafsson, Finn
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : 489 - 496